You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. A Dual Molecular/Tumor Targeting Therapy for PanCa

    SBC: SYNERGENE THERAPEUTICS INC            Topic: N/A

    DESCRIPTION (provided by applicant): Approximately 30,000 people in the United States are diagnosed each year with pancreatic cancer (PanCa). Over 90% of these will die of the disease making PanCa one of the most devastating human malignancies. The c

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  2. Advancing a Glioma Immunotherapy

    SBC: IN CYTU, INC.            Topic: 102

    DESCRIPTION provided by applicant A Phase II SBIR program of preclinical development is proposed for the development of an active specific immunotherapeutic called Cellariumandquot for treatment of glial cell based cancers Successful completion of this project will confirm therapeutic effect and pre clinical safety of the vaccine in preparation for first in human studies Upon demonstration of ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  3. Computerized Adaptive Version of the PEDI

    SBC: QUALITYMETRIC, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Our objective is to achieve a major advance in the technology used to assess disability in children and youth. Measurement and practical requirements for identifying disability and evaluating individual progress ac

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  4. Development Of An Online Approach To Informed Consent

    SBC: HEALTHMARK MULTIMEDIA, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): In this Phase II SBIR, HealthMark Multimedia proposes to evaluate the use of the prototype multimedia online informed consent process developed in Phase I with a cancer clinical trial and to further refine the proc

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  5. Development of Resource Kit for Adolescent Cessation

    SBC: Toborg Associates, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Five hundred thirty-four counties in 18 states are home to 29,497,852 persons and grow tobacco. Data indicate youth in these areas use tobacco earlier and use it more frequently. Tobacco communities have a unique per

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  6. Enhanced DNA microarray performance with patterned probe

    SBC: GENESPECTRUM            Topic: N/A

    DESCRIPTION (provided by applicant): The goal of the proposed research is to develop a method for significantly improving the performance of sequencing by hybridization (SBH), thus decreasing the cost and increasing the speed of sequencing DNA. If succ

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  7. I Live Inspired Individually Tailored and Integrated Social Support Network for Tobacco Cessation

    SBC: Live Inspired, LLC            Topic: NIDA

    DESCRIPTION provided by applicant Smoking kills Americans annually exacerbates myriad diseases and costs billions in healthcare and productivity losses Numerous barriers exist to accessing traditional treatment e g costs traveling to and scheduling appointments other logistics Text messaging is an extremely popular communication method Over of all Americans use text m ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  8. Implantable Noise-based Sensory Enhancement Devices

    SBC: AFFERENT CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Stroke survivors constitute one of the largest groups of patients receiving rehabilitation services in the United States. The inability of most stroke survivors to regain full sensorimotor function significantly imp

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  9. In Situ Autovaccination against Solid Cancers with Intratumoral Hiltonol Poly ICLC A phase II Adaptive Multicenter Clinical Study

    SBC: Oncovir            Topic: 102

    DESCRIPTION provided by applicant Hiltonol poly ICLC is a stabilized dsRNA therapeutic viral mimic or andapos danger signalandapos that activates multiple elements of innate and adaptive immunity It is a standalone immunomodulator but when properly combined with antigen it generates a comprehensive Th weighted immune response best suited for antiviral and antitumor action This project ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  10. NEUROSCI-BASED COGNITIVE TESTS AS OUTCOMES MEASURES PROJ

    SBC: SENTION, INC.            Topic: N/A

    N/A

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government